A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers

Clinical trial NCT00624663 · COMPLETED

Trial details

NCT number: NCT00624663
Sponsor: Tel-Aviv Sourasky Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Rivastigmine Toxicity

Start date: 2009-01-01
Primary completion: 2009-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.